Related references
Note: Only part of the references are listed.Tropomyosin Ser-283 pseudo-phosphorylation slows myofibril relaxation
Benjamin R. Nixon et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
The Tropomyosin Binding Region of Cardiac Troponin T Modulates Crossbridge Recruitment Dynamics in Rat Cardiac Muscle Fibers
Sampath K. Gollapudi et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy
Xiaochuan (Edward) Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Long-Range Effects of Familial Hypertrophic Cardiomyopathy Mutations E180G and D175N on the Properties of Tropomyosin
Socheata Ly et al.
BIOCHEMISTRY (2012)
CKIP-1 Inhibits Cardiac Hypertrophy by Regulating Class II Histone Deacetylase Phosphorylation Through Recruiting PP2A
Shukuan Ling et al.
CIRCULATION (2012)
Familial hypertrophic cardiomyopathy related E180G mutation increases flexibility of human cardiac α-tropomyosin
Campion K. P. Loong et al.
FEBS LETTERS (2012)
Tropomyosin Dephosphorylation Results in Compensated Cardiac Hypertrophy
Emily M. Schulz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts
Priya Muthu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Persistence Length of Human Cardiac α-Tropomyosin Measured by Single Molecule Direct Probe Microscopy
Campion K. P. Loong et al.
PLOS ONE (2012)
Thin Filament Mutations Developing an Integrative Approach to a Complex Disorder
Jil C. Tardiff
CIRCULATION RESEARCH (2011)
Loss of the AE3 anion exchanger in a hypertrophic cardiomyopathy model causes rapid decompensation and heart failure
Nabeel J. Al Moamen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein
Robert D. Gaffin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Localization of the two tropomyosin-binding sites of troponin T
J. -P. Jin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Molecular and Functional Characterization of a Novel Cardiac-Specific Human Tropomyosin Isoform
Sudarsan Rajan et al.
CIRCULATION (2010)
Research Priorities in Hypertrophic Cardiomyopathy Report of a Working Group of the National Heart, Lung, and Blood Institute
Thomas Force et al.
CIRCULATION (2010)
Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice
Brandon J. Biesiadecki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy
Yuejin Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy
James R. Pena et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Striated muscle tropomyosin isoforms differentially regulate cardiac performance and myofilament calcium sensitivity
Ganapathy Jagatheesan et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2010)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2009)
Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy
Chad M. Warren et al.
PROTEOMICS (2008)
Myofilament proteins: From cardiac disorders to proteomic changes
Chao Yuan et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Divergent regulation of the sarcomere and the cytoskeleton
Galina Schevzov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein kinase C ζ -: A novel regulator of both phosphorylation and de-phosphorylation of cardiac sarcomeric proteins
Steven C. Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis
Ganapathy Jagatheesan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
Impact of beta-myosin heavy chain expression on cardiac function during stress
M Krenz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked α-tropomyosin mutations
P Coutu et al.
CIRCULATION RESEARCH (2004)
A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation
R Prabhakar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Phospholamban: A crucial regulator of cardiac contractility
DH MacLennan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Functional importance of the carboxyl-terminal region of striated muscle tropomyosin
G Jagatheesan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Calcium cycling in congestive heart failure
G Hasenfuss et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice
R Prabhakar et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Constitutive association of c-N-Ras with c-Raf-1 and protein kinase Cε in latent signaling modules
M Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure
F del Monte et al.
CIRCULATION RESEARCH (2001)
Localization and kinetics of protein kinase C-epsilon anchoring in cardiac myocytes
SL Robia et al.
BIOPHYSICAL JOURNAL (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists
GX Chu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban
AG Brittsan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
